lysine has been researched along with Brain Diseases, Metabolic, Familial in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bouchereau, J; Schiff, M | 1 |
| Achouri, Y; Gailly, P; Marbaix, E; Marie, S; Rzem, R; Schakman, O; Van Schaftingen, E; Veiga-da-Cunha, M; Vincent, MF; Wiame, E | 1 |
| Aldred, S; Fitzgerald, M; Moore, KM; Waring, RH | 1 |
| Morton, DH; Puffenberger, EG; Robinson, DL; Strauss, KA | 1 |
| Andreassi, JL; Leyh, TS | 1 |
| Hoffmann, GF; Koeller, DM; Kölker, S; Okun, JG; Sauer, SW | 1 |
| Cheng, KC; Connor, JR; Goodman, SI; Housman, C; Jacobs, RE; LaNoue, K; Lazovic, J; O'Callaghan, JP; Simpson, I; Woontner, M; Zinnanti, WJ | 1 |
| Hasegawa, Y; Kimura, M; Komai, K; Samuraki, M; Terada, N; Yamada, M; Yamaguchi, S | 1 |
1 review(s) available for lysine and Brain Diseases, Metabolic, Familial
| Article | Year |
|---|---|
Inherited Disorders of Lysine Metabolism: A Review.
Topics: 2-Aminoadipic Acid; Aldehyde Dehydrogenase; Amino Acid Metabolism, Inborn Errors; Arginine; Brain; Brain Diseases, Metabolic; Brain Diseases, Metabolic, Inborn; Carnitine; Epilepsy; Glutarates; Glutaryl-CoA Dehydrogenase; Humans; Lysine; Metabolic Diseases; Pyridoxal Phosphate; Pyridoxine | 2020 |
7 other study(ies) available for lysine and Brain Diseases, Metabolic, Familial
| Article | Year |
|---|---|
A mouse model of L-2-hydroxyglutaric aciduria, a disorder of metabolite repair.
Topics: Alcohol Oxidoreductases; Animals; Arginine; Brain; Brain Diseases, Metabolic, Inborn; Cells, Cultured; Disease Models, Animal; Female; Glutarates; Ketone Oxidoreductases; Lysine; Male; Mice; Mice, Knockout; Testis | 2015 |
Plasma amino acid levels in children with autism and their families.
Topics: Adolescent; Alanine; Amino Acids; Asparagine; Asperger Syndrome; Autistic Disorder; Brain Diseases, Metabolic, Inborn; Child; Child, Preschool; Family; Female; Glutamic Acid; Glutamine; Humans; Lysine; Male; Phenylalanine; Tyrosine | 2003 |
Type I glutaric aciduria, part 1: natural history of 77 patients.
Topics: Brain Diseases, Metabolic, Inborn; Chromosomes, Human, Pair 19; Dystonia; Glutarates; Glutaryl-CoA Dehydrogenase; Humans; Lysine; Magnetic Resonance Imaging; Mutation; Necrosis; Oxidoreductases Acting on CH-CH Group Donors; Putamen; Tryptophan | 2003 |
Molecular functions of conserved aspects of the GHMP kinase family.
Topics: Alanine; Amino Acid Motifs; Amino Acid Substitution; Aspartic Acid; Binding Sites; Brain Diseases, Metabolic, Inborn; Catalytic Domain; Conserved Sequence; Humans; Kinetics; Lysine; Mevalonic Acid; Models, Molecular; Multigene Family; Phosphotransferases (Phosphate Group Acceptor); Protein Structure, Secondary; Serine; Streptococcus pneumoniae; Substrate Specificity | 2004 |
Lysine intake and neurotoxicity in glutaric aciduria type I: towards a rationale for therapy?
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic, Inborn; Diet; Disease Models, Animal; Glutarates; Lysine; Mice | 2006 |
Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I.
Topics: Aging; Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic, Inborn; Child; Diet; Disease Models, Animal; gamma-Aminobutyric Acid; Genetic Predisposition to Disease; Glucose; Glutamic Acid; Glutarates; Glutaryl-CoA Dehydrogenase; Homoarginine; Humans; Lysine; Mice; Mice, Knockout; Mitochondria; Neurons; Nuclear Magnetic Resonance, Biomolecular; Tryptophan | 2007 |
A successfully treated adult patient with L-2-hydroxyglutaric aciduria.
Topics: Adult; Age Factors; Alcohol Oxidoreductases; Brain; Brain Diseases, Metabolic; Brain Diseases, Metabolic, Inborn; Carnitine; Chromosomes, Human, Pair 14; Female; Flavin-Adenine Dinucleotide; Genetic Markers; Genetic Predisposition to Disease; Homozygote; Humans; Intellectual Disability; Lysine; Magnetic Resonance Imaging; Movement Disorders; Treatment Outcome | 2008 |